Dextromethorphan Abuse Reduction Act of 2009
Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.
Dextromethorphan Abuse Reduction Act of 2009 - Amends the Controlled Substances Act to prohibit sales of products containing dextromethorphan (including cough medicines) to individuals under age 18, including sales using the Internet, and to impose civil penalties for such sales.
Directs the Director of National Drug Control Policy to provide grants to certain nonprofit drug prevention entities, including the National Community Antidrug Coalition Institute, for antidrug educational campaigns aimed at individuals under age 18 and for assistance to community antidrug coalitions to prevent abuse of prescription and nonprescription drugs (including dextromethorphan).
Directs the Administrator of the Substance Abuse and Mental Health Services Administration of the Department of Health and Human Services (HHS) to make grants to implement comprehensive community-wide strategies for preventing abuse of prescription and nonprescription drugs (including dextromethorphan).
Read twice and referred to the Committee on the Judiciary. (text of measure as introduced: CR S7098-7099)
- Introduced in Senate Formatted Text PDF Formatted XML
Cite this page
U.S. Congress. (2026). S. 1383: Dextromethorphan Abuse Reduction Act of 2009. 111th Congress. Open America. https://openamerica.io/bill/111-S-1383/
"S. 1383: Dextromethorphan Abuse Reduction Act of 2009." 111th Congress, 2026, Open America, https://openamerica.io/bill/111-S-1383/.
S. 1383, 111th Cong. (2026), https://openamerica.io/bill/111-S-1383/.
[S. 1383: Dextromethorphan Abuse Reduction Act of 2009](https://openamerica.io/bill/111-S-1383/)